未登录 分享 收藏
分享 收藏
分享 收藏
The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK 罕见疗法启动平台：英国个体化药物的试点项目 O'Connor, Daniel J.; Moss, Parker; Wood, Matthew; Murphy, Martin; Blackwood, Nicola; Brown, Matthew A.; Lancaster, Deb; Newman, Vanessa; Taylor, Jenny; Yu, Tim; Vitarello, Julia 分享 收藏
分享 收藏
分享 收藏
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable 推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解 Yap, Christina; Aiyegbusi, Olalekan Lee; Alger, Emily; Basch, Ethan; Bell, Jill; Bhatnagar, Vishal; Cella, David; Collis, Philip; Dueck, Amylou C.; Gilbert, Alexandra; Gnanasakthy, Ari; Greystoke, Alastair; Hansen, Aaron R.; Kamudoni, Paul; Kholmanskikh, Olga; King-Kallimanis, Bellinda L.; Krumholz, Harlan; Minchom, Anna; O'Connor, Daniel; Petrie, Joan; Piccinin, Claire; Rantell, Khadija Rerhou; Rauz, Saaeha; Retzer, Ameeta; Rizk, Steven; Wagner, Lynne; Sasseville, Maxime; Seymour, Lesley K.; Weber, Harald A.; Wilson, Roger; Calvert, Melanie; Peipertf, John Devin 分享 收藏
Drug repurposing for rare: progress and opportunities for the rare disease community Jonker, Anneliene Hechtelt; O'Connor, Daniel; Cavaller-Bellaubi, Maria; Fetro, Christine; Gogou, Maria; Hoen, Peter A. C. T.; de Kort, Martin; Stone, Heather; Valentine, Nivedita; Pasmooij, Anna Maria Gerdina 分享 收藏
分享 收藏
分享 收藏
分享 收藏
The value of patient-reported outcomes in early-phase clinical trials Retzer, Ameeta; Aiyegbusi, Olalekan Lee; Rowe, Anna; Newsome, Philip N.; Douglas-Pugh, Jessica; Khan, Sheeba; Mittal, Saloni; Wilson, Roger; O'Connor, Daniel; Campbell, Lisa; Mitchell, Sandra A.; Calvert, Melanie 分享 收藏
分享 收藏
分享 收藏
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity Mukhopadhyay, Anandaroop; Nguyen, Bianca; Lee, Jack Y.; Han, Mia; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Browning, Erica; O'Connor, Daniel J.; Canton, David A.; Fisher, Daniel; Skitzki, Joseph; Twitty, Christopher G. 分享 收藏
分享 收藏
Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations Vreman, Rick A.; de Ruijter, Angela S.; Zawada, Anna; Tafuri, Giovanni; Stoyanova-Beninska, Violeta; O'Connor, Daniel; Naumann-Winter, Frauke; Wolter, Franziska; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.; Sidiropoulos, Iordanis; Larsson, Kristina; Goettsch, Wim G. 分享 收藏
The important role of the histopathologist in clinical trials: challenges and approaches to tackle them Provenzano, Elena; Driskell, Owen J.; O'Connor, Daniel J.; Rodriguez-Justo, Manuel; McDermott, Jacqueline; Wong, Newton; Kendall, Timothy; Zhang, Yu Zhi; Robinson, Max; Kurian, Kathreena M.; Pell, Robert; Shaaban, Abeer M. 分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
